144702-26-1,
Telmisartan tert-Butyl Ester,
Telmisartan Impurity C,
4'-[[1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl]-methyl]-1,1'-biphenyl-2-carboxylic acid 1,1-dimethylethyl ester,
UNII-H4HLP8PW27,
H4HLP8PW27,
[1,1'-Biphenyl]-2-carboxylicacid, 4'-[(1,4'-dimethyl-2'-propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-,1,1-dimethylethyl ester,
(1,1'-Biphenyl)-2-carboxylic acid, 4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-, 1,1-dimethylethyl ester,
1,1-Dimethylethyl 4'-((4-methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazol-1-yl)methyl)biphenyl-2-carboxylate,
4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1h-benzimidazol)-1'-yl)-methyl)-1,1'-biphenyl-2-carboxylic acid 1,1-dimethylethyl ester,
tert-butyl 2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propyl-benzimidazol-1-yl]methyl]phenyl]benzoate,
Tacrolimus methylacryl aldehyde,
[1,1'-Biphenyl]-2-carboxylic acid, 4'-[(1,4'-dimethyl-2'-propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-, 1,1-dimethylethyl ester,
1,1-dimethylethyl 4'-[[4-methyl-6-(1-methyl-1h-benzimidazol-2-yl)-2-propyl-1h-benzimidazol-1-yl]methyl]biphenyl-2-carboxylate,
Telmisartan specified impurity C [EP],
ACMC-1C4TA,
telmisartan ep impurity c,
SCHEMBL170874,
BIP025,
CTK4C4179,
DTXSID10162789,
Tacrolimus impurity, tacrolimus methylacryl aldehyde- [USP],
Telmisartan impurity, telmisartan tert-butyl ester- [USP],
JSCFLEBEWCTASN-UHFFFAOYSA-N,
C37H38N4O2,
MFCD09752830,
ZINC67665431,
(E)-3-((1R,3R,4R)-4-Hydroxy-3-methoxycyclohexyl)-2-methylacrylaldehyde,
AKOS015896036,
2-Propenal, 3-(4-hydroxy-3-methoxycyclohexyl)-2-methyl-, (1R-(1alpha(E),3alpha,4beta))-,
AC-26340,
AN-31310,
Q988,
TL8000992,
FT-0657482,
J3.655.350B,
702D261,
A808271,
I06-1854,
J-007999,
[1,1'-Biphenyl]-2-carboxylic acid, 4'-[[4-methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzomidazol-1-yl]methyl]-, 1,1-dimethylethyl ester,
2-[4-[[4-methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl]methyl]phenyl]benzoic acid tert-butyl ester,
4'-[(1,4'-Dimethyl-2'-propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic Acid 1,1-Dimethylethyl Ester,
4'-[[1,4'-DIMETHYL-2'-PROPYL(2,6'-BI-1H-BENZIMIDAZOL)-1'-YL]-METHYL]-1,1'-BIPHENYL-2-CARBOXYLICACID1,1-DIMETHYLETHYLESTER,
4'-[[1,4'-Dimethyl-2'-propyl-2,6'-bi[1H-benzoimidazole]-1'-yl]methyl]-1,1'-biphenyl-2-carboxylic acid tert-butyl ester,
tert-Butyl 4'-((1,7'-dimethyl-2'-propyl-1H,3'H-[2,5'-bibenzo[d]imidazol]-3'-yl)methyl)-[1,1'-biphenyl]-2-carboxylate,
tert-butyl 4'-[[2-n-propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)benzimidazol-1-yl]methyl]biphenyl-2-carboxylate,
tert.-butyl 4'-[[2-n-propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)-benzimidazol-1-yl]-methyl]-biphenyl-2-carboxylate,
Telmisartan,
Telmisartantert-butylester,
Telmisartan EP Impurity C,
CS-O-08260,
CID10076748,
CID 10076748,
144701-48-4,
4'-[[1,4'-Dimethyl-2'-propyl -1'-yl]-methyl]-1,1'-biphenyl-2-carboxylicacid1,1-dimethylethylester,
4'[(1,4'-DIMETHYL-2'-PROPYL[2,6'-BI-1H-BENZIMIDAZOL]-1'-YL)METHYL][1,1'-BIPHENYL]-2-CARBOXYLIC ACID,